151 related articles for article (PubMed ID: 35773692)
1. Effects of body mass index and serum albumin on overall survival in patients with cancer undergoing pancreaticoduodenectomy: a single-center retrospective cohort study.
Cui L; Yu H; Sun Q; Miao Y; Jiang K; Fang X
World J Surg Oncol; 2022 Jul; 20(1):221. PubMed ID: 35773692
[TBL] [Abstract][Full Text] [Related]
2. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
3. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
4. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Glasgow prognostic score predicts survival among patients with high PD-L1 expression administered first-line pembrolizumab monotherapy for non-small cell lung cancer.
Imai H; Kishikawa T; Minemura H; Yamada Y; Ibe T; Yamaguchi O; Mouri A; Hamamoto Y; Kanazawa K; Kasai T; Kaira K; Kaburagi T; Minato K; Kobayashi K; Kagamu H
Cancer Med; 2021 Oct; 10(20):6971-6984. PubMed ID: 34414673
[TBL] [Abstract][Full Text] [Related]
6. Predictive nomogram for postoperative pancreatic fistula following pancreaticoduodenectomy: a retrospective study.
Shen J; Guo F; Sun Y; Zhao J; Hu J; Ke Z; Zhang Y; Jin X; Wu H
BMC Cancer; 2021 May; 21(1):550. PubMed ID: 33992090
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma.
Sunil BJ; Seshadri RA; Gouthaman S; Ranganathan R
J Gastrointest Cancer; 2017 Mar; 48(1):13-19. PubMed ID: 27484980
[TBL] [Abstract][Full Text] [Related]
8. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
9. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
10. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
11. Nutritional assessment and prognosis of oral cancer patients: a large-scale prospective study.
Bao X; Liu F; Lin J; Chen Q; Chen L; Chen F; Wang J; Qiu Y; Shi B; Pan L; Lin L; He B
BMC Cancer; 2020 Feb; 20(1):146. PubMed ID: 32087695
[TBL] [Abstract][Full Text] [Related]
12. The Comparison of Inflammation-Based Prognostic Scores in Patients With Extrahepatic Bile Duct Cancer After Pancreaticoduodenectomy.
Fujiwara Y; Haruki K; Shiba H; Hamura R; Shirai Y; Furukawa K; Gocho T; Yanaga K
J Surg Res; 2019 Jun; 238():102-112. PubMed ID: 30769246
[TBL] [Abstract][Full Text] [Related]
13. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
14. Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.
Hendifar A; Osipov A; Khanuja J; Nissen N; Naziri J; Yang W; Li Q; Tuli R
PLoS One; 2016; 11(3):e0152172. PubMed ID: 27015568
[TBL] [Abstract][Full Text] [Related]
15. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
16. Combination of body mass index and albumin predicts the survival in metastatic castration-resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials.
Pan J; Wang J; Wei Y; Zhang T; Zhang S; Ye D; Zhu Y
Cancer Med; 2021 Oct; 10(19):6697-6704. PubMed ID: 34414685
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors of postoperative complications of pancreatoduodenectomy].
He KJ; Jiao XY; Yang XW; Hu YZ
Ai Zheng; 2008 Jan; 27(1):75-7. PubMed ID: 18184469
[TBL] [Abstract][Full Text] [Related]
18. Oncologic and Perioperative Outcomes Following Selective Application of Laparoscopic Pancreaticoduodenectomy for Periampullary Malignancies.
Delitto D; Luckhurst CM; Black BS; Beck JL; George TJ; Sarosi GA; Thomas RM; Trevino JG; Behrns KE; Hughes SJ
J Gastrointest Surg; 2016 Jul; 20(7):1343-9. PubMed ID: 27142633
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the lymph node ratio after resection of periampullary carcinomas.
Farid SG; Falk GA; Joyce D; Chalikonda S; Walsh RM; Smith AM; Morris-Stiff G
HPB (Oxford); 2014 Jun; 16(6):582-91. PubMed ID: 23777362
[TBL] [Abstract][Full Text] [Related]
20. Influence of Body Mass Index on Perioperative Outcomes Following Pancreaticoduodenectomy.
Tang T; Tan Y; Xiao B; Zu G; An Y; Zhang Y; Chen W; Chen X
J Laparoendosc Adv Surg Tech A; 2021 Sep; 31(9):999-1005. PubMed ID: 33181060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
